Off Doc 200mg/500mg Tablet is a combination antibiotic formulation containing Ofloxacin 200mg and Ornidazole 500mg, designed for the treatment of a broad spectrum of bacterial and protozoal infections. Ofloxacin, a fluoroquinolone antibiotic, exerts its bactericidal action by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription in susceptible organisms. Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa by causing DNA strand breakage and inhibition of nucleic acid synthesis. This synergistic combination is particularly useful in managing mixed infections involving both aerobic and anaerobic pathogens, such as gastrointestinal infections, genitourinary tract infections, respiratory tract infections, and certain sexually transmitted infections. Off Doc tablets should be administered as prescribed by a healthcare professional, with dosage adjusted according to the severity of infection and patient-specific factors including renal function. Caution is advised in patients with a history of hypersensitivity to fluoroquinolones or nitroimidazoles, and potential side effects may include gastrointestinal disturbances, dizziness, and hypersensitivity reactions. Complete the full course of therapy to prevent resistance development and ensure optimal clinical outcomes.